FGC
REGN icon

Financial Gravity Companies’s Regeneron Pharmaceuticals REGN Stock Holding History

Financial Gravity Companies’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$283K Buy
+657
New +$240K 0.26% 78
2018
Q1 		$211K Buy
714
+502
+237% +$175K 0.22% 84
2017
Q4 		$78K Buy
+212
New +$85.9K 0.09% 217

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Financial Gravity Companies's REGN Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2018: 657 shares worth $283K. The stake represents 0.26% of the portfolio and ranks #78 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in REGN as recently as Q1 2018.

Financial Gravity Companies first reported a position in REGN in Q4 2017 and has held it in 3 quarters since. 670 funds tracked by Wall St. Rank hold REGN as of Q4 2018.

  • Financial Gravity Companies held 657 shares of Regeneron Pharmaceuticals worth $283K as of Q4 2018.
  • Regeneron Pharmaceuticals was a new Financial Gravity Companies position in Q4 2018.
  • Regeneron Pharmaceuticals made up 0.26% of Financial Gravity Companies's portfolio in Q4 2018, its #78 holding.
  • Financial Gravity Companies first reported a position in Regeneron Pharmaceuticals in Q4 2017 and has held it in 3 quarters since.
  • 670 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.